Home NDC 33342-088-52 NDC 33342-088-52 - Rizatriptan Benzoate This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 33342-088
Requested NDC 33342-088-52
Package NDCs from labels 33342-088-07, 33342-088-46, 33342-088-12, 33342-088-52, 33342-088-50, 33342-088-72, 33342-088-02, 33342-088-45, 33342-088-41
Manufacturer Direct_Rx
Effective date 2026-03-17
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 33342-088-02 Rizatriptan 6 in 1 BLISTER PACK TABLET, FILM COATED 6 7 33342-088-07 Rizatriptan 30 in 1 CONTAINER TABLET, FILM COATED 30 7 33342-088-12 Rizatriptan 10 in 1 CARTON TABLET, FILM COATED 10 7 33342-088-12 Rizatriptan 10 in 1 BLISTER PACK TABLET, FILM COATED 10 7 33342-088-41 Rizatriptan 3 in 1 CARTON TABLET, FILM COATED 3 7 33342-088-45 Rizatriptan 2 in 1 CARTON TABLET, FILM COATED 2 7 33342-088-46 Rizatriptan 200 in 1 CONTAINER TABLET, FILM COATED 200 7 33342-088-50 Rizatriptan 4 in 1 CARTON TABLET, FILM COATED 4 7 33342-088-52 Rizatriptan 3 in 1 BLISTER PACK TABLET, FILM COATED 3 7 33342-088-72 Rizatriptan 6 in 1 CARTON TABLET, FILM COATED 6 7
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 33342-088 RIZATRIPTAN TABLET, FILM COATED [MACLEODS PHARMACEUTICALS LIMITED] 7 Current NDC, Legacy NDC, 10 package rows 20220703_27bc2cfc-fefb-4b50-a0dc-6268c69b4902.zip
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded RIZATRIPTAN BENZOATE ACTIVE INGREDIENT WR978S7QHH RIZATRIPTAN TABLET, FILM COATED [MACLEODS PHARMACEUTICALS LIMITED] 2 RIZATRIPTAN ACTIVE MOIETY 51086HBW8G RIZATRIPTAN TABLET, FILM COATED [MACLEODS PHARMACEUTICALS LIMITED] 2 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U RIZATRIPTAN TABLET, FILM COATED [MACLEODS PHARMACEUTICALS LIMITED] 2 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 RIZATRIPTAN TABLET, FILM COATED [MACLEODS PHARMACEUTICALS LIMITED] 2 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X RIZATRIPTAN TABLET, FILM COATED [MACLEODS PHARMACEUTICALS LIMITED] 2 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 RIZATRIPTAN TABLET, FILM COATED [MACLEODS PHARMACEUTICALS LIMITED] 2 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ RIZATRIPTAN TABLET, FILM COATED [MACLEODS PHARMACEUTICALS LIMITED] 2
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 6 of 6 · 112 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Rizatriptan Benzoate RIZATRIPTAN BENZOATE Bryant Ranch Prepack 65ae33a2-975f-4a4e-a1a5-42fe451a2434 2023-03-23 Warnings, Adverse reactions Exact identifier rxcui: 312840 unii: WR978S7QHH rizatriptan benzoate RIZATRIPTAN BENZOATE Macleods Pharmaceuticals Limited 57ed2505-28f1-4292-b3c3-a49bf0f7c683 2023-02-27 Boxed warning, Warnings, Adverse reactions Exact identifier unii: WR978S7QHH Rizatriptan Benzoate RIZATRIPTAN BENZOATE A-S Medication Solutions 5001b8cc-8e52-4a00-a830-3b2f79766a03 2023-02-06 Warnings, Adverse reactions Exact identifier rxcui: 314209 unii: WR978S7QHH Rizatriptan Benzoate RIZATRIPTAN BENZOATE Unichem Pharmaceuticals (USA), Inc. 35f26d3c-268b-4114-9b5b-1c2e0b9ddfd5 2022-11-22 Warnings, Adverse reactions Exact identifier rxcui: 314209 rxcui: 312840 unii: WR978S7QHH Rizatriptan Benzoate RIZATRIPTAN BENZOATE Ascend Laboratories, LLC 07e66554-bc85-4853-9f40-1249617630a9 2022-09-30 Warnings, Adverse reactions Exact identifier rxcui: 314209 rxcui: 312840 unii: WR978S7QHH Rizatriptan RIZATRIPTAN Macleods Pharmaceuticals Limited 27bc2cfc-fefb-4b50-a0dc-6268c69b4902 2022-07-01 Warnings, Adverse reactions Exact identifier application number: ANDA203147 ndc (package): 33342-088-52 ndc (package): 33342-088-46 ndc (package): 33342-087-52 ndc (package): 33342-088-41 ndc (package): 33342-088-72 ndc (package): 33342-087-46 ndc (package): 33342-088-12 ndc (package): 33342-087-12 ndc (package): 33342-087-50 ndc (package): 33342-087-41 ndc (package): 33342-087-07 ndc (package): 33342-087-72 ndc (package): 33342-088-07 ndc (package): 33342-088-50 ndc (package): 33342-087-02 ndc (package): 33342-088-02 ndc (package): 33342-088-45 ndc (package): 33342-087-45 ndc (product): 33342-088 ndc (product): 33342-087 ndc11 (package): 33342008852 rxcui: 314209 rxcui: 312840 spl id: fe80232a-c329-47ed-8edd-7786e06f3c08 spl set id: 27bc2cfc-fefb-4b50-a0dc-6268c69b4902 unii: WR978S7QHH Rizatriptan Benzoate RIZATRIPTAN BENZOATE Proficient Rx LP 4a5b43f6-a5ea-4d6f-941f-3c19f242c896 2022-05-01 Warnings, Adverse reactions Exact identifier rxcui: 314209 unii: WR978S7QHH Rizatriptan Benzoate RIZATRIPTAN BENZOATE Cipla USA Inc. f462a507-921c-41c2-93ba-36003b6e8914 2022-01-13 Warnings, Adverse reactions Exact identifier rxcui: 314209 rxcui: 312840 unii: WR978S7QHH RIZATRIPTAN BENZOATE RIZATRIPTAN BENZOATE Bionpharma Inc., 91e160d6-f23f-e5e0-baec-908b2d25ce3c 2021-03-02 Warnings, Adverse reactions Exact identifier unii: WR978S7QHH Rizatriptan Benzoate RIZATRIPTAN BENZOATE Unichem Pharmaceuticals (USA), Inc. 3cdeccf6-36dd-4a9e-9687-2f7cce47af5f 2020-04-08 Warnings, Adverse reactions Exact identifier unii: WR978S7QHH Rizatriptan Benzoate RIZATRIPTAN BENZOATE Proficient Rx LP f5520526-1cc5-489f-b142-92f92fec77d3 2020-02-01 Warnings, Adverse reactions Exact identifier unii: WR978S7QHH Rizatriptan Benzoate RIZATRIPTAN BENZOATE Teva Pharmaceuticals USA, Inc. 4ef60c83-ba48-4134-968b-13800ea9b7f2 2019-10-01 Warnings, Adverse reactions Exact identifier rxcui: 314209 rxcui: 312840 unii: WR978S7QHH
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.